Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates — StellaNot a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(22 sites)
United States
University of Arizona, Tucson, Arizona The George Washington University, Washington D.C., District of Columbia Canada
University of Alberta, Edmonton, Alberta University of British Columbia, Vancouver, British Columbia Dalhousie University, Halifax, Nova Scotia St. Joseph's Healthcare, Hamilton, Ontario Kingston Health Science Centre, Kingston, Ontario London Health Science Centre, London, Ontario The Ottawa Hospital Research Institute, Ottawa, Ontario University Health Network, Toronto, Ontario St Michael's Hospital, Toronto, Ontario CHU de Quebec-Universite Laval's L'Hotel-Dieu de Quebec, Laval, Quebec University of Montreal, Maisonneuve-Rosemont Hospital, Montreal, Quebec McGill University Health Centre, Montreal, Quebec Universite de Montreal, Hopital Maisonneuve-Rosemont, Montreal, Quebec Germany
Charité Universitätsmedizin, Berlin United Kingdom
Sussex Brighton R&D, Brighton King's College Hospital NHS Foundation Trust, Brixton Epsom and St Helier University Hospitals NHS Trust, Carshalton Barts Health NHS Trust, London St George's University Hospital NHS Trust Foundation, London St. Paul's Hospital, University of Saskatchewan, Saskatoon, Saskatchewan
Interested in joining?